DrugPatentWatch Database Preview
FORBAXIN Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Forbaxin, and what generic alternatives are available?
The generic ingredient in FORBAXIN is methocarbamol. There are twenty-seven drug master file entries for this compound. Fifty-eight suppliers are listed for this compound. Additional details are available on the methocarbamol profile page.
Summary for FORBAXIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 67 |
| Patent Applications: | 1,623 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | FORBAXIN at DailyMed |
Medical Subject Heading (MeSH) Categories for FORBAXIN
Synonyms for FORBAXIN
| (+-)-3-(o-Methoxyphenoxy)-1,2-propanediol 1-carbamate |
| (+/-)-3-( o-Methoxyphenoxy)-1,2-propanediol 1-carbamate |
| (RS)-2-hydroxy-3-(2-methoxyphenoxy)propyl carbamate |
| [2-hydroxy-3-(2-methoxyphenoxy)propyl] carbamate |
| [3-(2-methoxyphenoxy)-2-oxidanyl-propyl] carbamate |
| 1-carbamoyloxy-3-(2'-methoxyphenoxy)-2-propanol |
| 1, 3-(2-methoxyphenoxy)-, 1-carbamate |
| 1, 3-(o-methoxyphenoxy)-, 1-carbamate |
| 1,2-Propanediol, 3-(2-methoxyphenoxy)-, 1-carbamate |
| 1,2-Propanediol, 3-(o-methoxyphenoxy)-, 1-carbamate |
| 1,2-Propanediol,3-(2-methoxyphenoxy)-, 1-carbamate |
| 145308-03-8 |
| 2-hydroxy-3-(2-methoxyphenoxy)propyl aminooate |
| 2-Hydroxy-3-(2-methoxyphenoxy)propyl carbamate |
| 2-Hydroxy-3-(2-methoxyphenoxy)propyl carbamate # |
| 2-Hydroxy-3-(o-methoxyphenoxy)propyl 1-carbamate |
| 2-Hydroxy-3-(o-methoxyphenoxy)propyl carbamate |
| 2-hydroxy-3-{[2-(methyloxy)phenyl]oxy}propyl carbamate |
| 3-(2-Methoxyphenoxy)-1-glyceryl carbamate |
| 3-(o-Methoxyphenoxy)-1,2-propanediol 1-carbamate |
| 3-(o-Methoxyphenoxy)-2-hydroxypropyl carbamate |
| 3-O-(2-Methoxyphenyl)-1-glyceryl carbamate |
| 3967-43-9 |
| 3B1-005928 |
| 532-03-6 |
| A829442 |
| AB00052040 |
| AB00052040_16 |
| AB00052040_17 |
| AB00052040-15 |
| AB2000260 |
| AC-12037 |
| AC1L1HFD |
| ACM1189699704 |
| AHR 85 |
| AKOS015960743 |
| AN-23552 |
| ANW-42701 |
| API0003331 |
| AS-11691 |
| Avetil |
| BC203907 |
| BPBio1_000119 |
| BRD-A31521121-001-05-8 |
| BRN 1884446 |
| BSPBio_000107 |
| BSPBio_001991 |
| C11H15NO5 |
| carbamic acid [2-hydroxy-3-(2-methoxy-phenoxy)-propyl] ester |
| carbamic acid [2-hydroxy-3-(2-methoxyphenoxy)propyl] ester |
| Carbamic Acid 2-Hydroxy-3-(2-methoxyphenoxy)propyl Ester |
| Carbamic acid, 2-hydroxy-3-(o-methoxyphenoxy)propyl ester |
| CAS-532-03-6 |
| CCG-39655 |
| CHEBI:77498 |
| CHEMBL1201117 |
| CPD000058719 |
| CS-2248 |
| CTK8B3542 |
| D00402 |
| D0FN7J |
| DB00423 |
| Delaxin |
| Delaxin (TN) |
| DivK1c_000434 |
| DSSTox_CID_3286 |
| DSSTox_GSID_23286 |
| DSSTox_RID_76958 |
| DTXSID6023286 |
| EINECS 208-524-3 |
| EN300-119525 |
| Etroflex |
| FT-0628302 |
| Glycerylguaiacolate carbamate |
| Glycerylguajacol-carbamat |
| GNXFOGHNGIVQEH-UHFFFAOYSA-N |
| GTPL6829 |
| Guaiacol glyceryl ether carbamate |
| Guaiacol glyceryl ether carbamate, analytical standard |
| guaiamar carbamate |
| Guaiphenesin carbamate |
| Guaiphenesine carbamate |
| Guiacol-gliceriletere monocarbammato |
| HMS1568F09 |
| HMS1920L19 |
| HMS2091D14 |
| HMS2095F09 |
| HMS2233G18 |
| HMS3259M17 |
| HMS3369B17 |
| HMS3655O06 |
| HMS501F16 |
| HSDB 3122 |
| HY-B0262 |
| IDI1_000434 |
| KBio1_000434 |
| KBio2_001477 |
| KBio2_004045 |
| KBio2_006613 |
| KBio3_001491 |
| KBioGR_000517 |
| KBioSS_001477 |
| KS-00000GJG |
| LS-120555 |
| Lumirelax |
| M2254 |
| MCULE-7298838587 |
| Methacarbamol |
| Methocal |
| Methocarbamo |
| methocarbamol |
| Methocarbamol (JAN/USP/INN) |
| Methocarbamol (Robaxin) |
| Methocarbamol [INN:BAN:JAN] |
| Methocarbamol [USP:INN:BAN:JAN] |
| Methocarbamol, pharmaceutical secondary standard; traceable to USP |
| Methocarbamol, United States Pharmacopeia (USP) Reference Standard |
| Methocarbamolum |
| Methocarbamolum [INN-Latin] |
| Metocarbamol |
| Metocarbamol [INN-Spanish] |
| Metocarbamolo |
| Metocarbamolo [DCIT] |
| Metofenia |
| Metofenina |
| MFCD00057662 |
| Miolaxene |
| Miorilas |
| Miowas |
| MLS000028610 |
| MLS001148605 |
| MolPort-003-666-229 |
| Myolaxene |
| NC00509 |
| NCGC00016492-01 |
| NCGC00018257-02 |
| NCGC00018257-03 |
| NCGC00018257-04 |
| NCGC00018257-07 |
| NCGC00018257-08 |
| NCGC00089805-02 |
| NCGC00089805-03 |
| NE28012 |
| Neuraxin |
| NINDS_000434 |
| NSC 170960 |
| NSC-170960 |
| NSC-757112 |
| NSC170960 |
| NSC757112 |
| Opera_ID_1471 |
| OR057916 |
| OR207703 |
| OR279471 |
| Parabaxin |
| Perilax |
| Pharmakon1600-01500397 |
| Prestwick_614 |
| Prestwick0_000184 |
| Prestwick1_000184 |
| Prestwick2_000184 |
| Prestwick3_000184 |
| PubChem20751 |
| rac-methocarbamol |
| Reflexyn |
| Relestrid |
| RL03963 |
| Robamol |
| Robaxan |
| Robaxin |
| Robaxin (TN) |
| ROBAXIN-750 |
| Robaxine |
| Robaxisol |
| Robaxisol (Salt/Mix) |
| Robaxon |
| Robinax |
| Romethocarb |
| s1736 |
| SAM002554900 |
| SBB056990 |
| SBI-0051442.P003 |
| SC-13605 |
| SCHEMBL34365 |
| SMR000058719 |
| SPBio_001264 |
| SPBio_002028 |
| Spectrum_000997 |
| SPECTRUM1500397 |
| Spectrum2_001272 |
| Spectrum3_000496 |
| Spectrum4_000049 |
| Spectrum5_000956 |
| SR-01000000240 |
| SR-01000000240-2 |
| ST50993887 |
| Surquetil |
| Tox21_110454 |
| Tox21_110454_1 |
| Traumacut |
| Tresortil |
| WLN: ZVO1YQ1OR BO1 |
US Patents and Regulatory Information for FORBAXIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Forest Labs | FORBAXIN | methocarbamol | TABLET;ORAL | 085136-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
